256 related articles for article (PubMed ID: 17901956)
1. Complement in glomerular injury.
Berger SP; Daha MR
Semin Immunopathol; 2007 Nov; 29(4):375-84. PubMed ID: 17901956
[TBL] [Abstract][Full Text] [Related]
2. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
Noris M; Remuzzi G
Clin Exp Immunol; 2008 Feb; 151(2):199-209. PubMed ID: 18070148
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
[TBL] [Abstract][Full Text] [Related]
4. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.
Pickering MC; Cook HT
Clin Exp Immunol; 2008 Feb; 151(2):210-30. PubMed ID: 18190458
[TBL] [Abstract][Full Text] [Related]
5. Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement.
Noris M; Remuzzi G
Semin Nephrol; 2017 Sep; 37(5):447-463. PubMed ID: 28863792
[TBL] [Abstract][Full Text] [Related]
6. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.
de Cordoba SR; Tortajada A; Harris CL; Morgan BP
Immunobiology; 2012 Nov; 217(11):1034-46. PubMed ID: 22964229
[TBL] [Abstract][Full Text] [Related]
7. Anti-complement therapy for glomerular diseases.
Bomback AS
Adv Chronic Kidney Dis; 2014 Mar; 21(2):152-8. PubMed ID: 24602464
[TBL] [Abstract][Full Text] [Related]
8. Complement analysis in clinic and research.
Mollnes TE; Kirschfink M
Adv Exp Med Biol; 2006; 586():361-80. PubMed ID: 16893084
[No Abstract] [Full Text] [Related]
9. The role of complement in AMD.
Zipfel PF; Lauer N; Skerka C
Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
[TBL] [Abstract][Full Text] [Related]
10. Factor H family proteins and human diseases.
Józsi M; Zipfel PF
Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
[TBL] [Abstract][Full Text] [Related]
11. Complement and glomerular disease: new insights.
Pickering M; Cook HT
Curr Opin Nephrol Hypertens; 2011 May; 20(3):271-7. PubMed ID: 21422921
[TBL] [Abstract][Full Text] [Related]
12. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
[TBL] [Abstract][Full Text] [Related]
13. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
14. Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.
Alfakeeh K; Azar M; Alfadhel M; Abdullah AM; Aloudah N; Alsaad KO
Pediatr Nephrol; 2017 May; 32(5):885-891. PubMed ID: 28210841
[TBL] [Abstract][Full Text] [Related]
15. Complement dysregulation in glomerulonephritis.
Kaartinen K; Safa A; Kotha S; Ratti G; Meri S
Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769
[TBL] [Abstract][Full Text] [Related]
16. Update on evaluating complement in hemolytic uremic syndrome.
Kavanagh D; Goodship TH
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic mechanisms in membranoproliferative glomerulonephritis.
Smith KD; Alpers CE
Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):396-403. PubMed ID: 15931011
[TBL] [Abstract][Full Text] [Related]
18. Complement regulatory genes and hemolytic uremic syndromes.
Kavanagh D; Richards A; Atkinson J
Annu Rev Med; 2008; 59():293-309. PubMed ID: 17705684
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H and haemolytic uraemic syndrome.
Mathieson P
Lancet; 2002 Mar; 359(9308):801-2. PubMed ID: 11888630
[No Abstract] [Full Text] [Related]
20. The spectrum of complement alternative pathway-mediated diseases.
Holers VM
Immunol Rev; 2008 Jun; 223():300-16. PubMed ID: 18613844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
